FDA defends lab test rule, as critics fear industry upheaval
BioPharma
Source: biopharmadive.com
Stay updated with breaking news from Clinical Laboratory Evaluation Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Agency will treat lab-developed tests the same as other in vitro diagnostics
Today, the U.S. Food and Drug Administration took action aimed at helping to ensure the safety and effectiveness of laboratory developed tests.
/PRNewswire/ -- PreciseDx®, a leading innovator in oncology diagnostics leveraging Artificial Intelligence (AI) for revolutionary, morphology-driven disease...
After an over decade-long discourse amongst interested stakeholders, on October 3, 2023, FDA unveiled its proposed rule and policy to increase oversight over LDTs.